Login

One (1) Category 1A CME Credit available for this course.

Objectives:

  1. Identify pre-transfusion considerations
  2. Enumerate the appropriate steps for safe transfusion and identify which products are indicated given the clinical setting 
  3. Describe post transfusion reactions

Needs:

  1. Advances in medical knowledge
  2. Legislative, regulatory, or organizational changes affecting patient care

References:

Shah A, Stanworth SJ, McKechnie S. Evidence and triggers for the transfusion of blood and blood products. Anaesthesia. 2015 Jan;70 Suppl 1:10-9, e3-5. [PubMed]

Pybus S, MacCormac A, Houghton A, Martlew V, Thachil J. Inappropriateness of fresh frozen plasma for abnormal coagulation tests. J R Coll Physicians Edinb. 2012;42(4):294-300. [PubMed]

Müller MC, Arbous MS, Spoelstra-de Man AM, Vink R, Karakus A, Straat M, Binnekade JM, de Jonge E, Vroom MB, Juffermans NP. Transfusion of fresh-frozen plasma in critically ill patients with a coagulopathy before invasive procedures: a randomized clinical trial (CME). Transfusion. 2015 Jan;55(1):26-35; quiz 25. [PubMed]

Tran HA, Chunilal SD, Tran H. An update of consensus guidelines for warfarin reversal. Med J Aust. 2014 Feb 03;200(2):82. [PubMed]

Core Competencies: 2,3,4,5,6